TURTLE CAMERON (Chief Executive Officer) sold 2.3% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $632.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001636282-26-000026
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$632.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.90K
Price / share
$41.73
Trade value
$246.21K
% of position
0.9%
3/2/2026
657.54K→651.64K
Common Stock
Direct
Shares
−9.10K
Price / share
$42.49
Trade value
$386.66K
% of position
1.4%
3/2/2026
651.64K→642.54K
Total
Net shares
−15K
Net value
-$632.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −5.90K | $41.73 | $246.21K | 0.9% | 657.54K | 651.64K |
| Common Stock Direct | 3/2/2026 | S · Sale | −9.10K | $42.49 | $386.66K | 1.4% | 651.64K | 642.54K |
| Total | −15K | -$632.87K | ||||||
Derivative Transactions0
No derivative transactions reported